Advertisement
UK markets open in 50 minutes

  • NIKKEI 225

    37,126.87
    -952.83 (-2.50%)
     

  • HANG SENG

    16,144.11
    -241.76 (-1.48%)
     

  • CRUDE OIL

    84.44
    +1.71 (+2.07%)
     

  • GOLD FUTURES

    2,394.50
    -3.50 (-0.15%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • Bitcoin GBP

    49,930.64
    +661.78 (+1.34%)
     

  • CMC Crypto 200

    1,284.29
    -28.34 (-2.12%)
     

  • NASDAQ Composite

    15,601.50
    -81.87 (-0.52%)
     

  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

Information on the total number of voting rights and shares

Biotalys
·2-min read

Ghent, BELGIUM, Aug. 03, 2021 (GLOBE NEWSWIRE) --

Press release - regulated information

Information on the total number of voting rights and shares

Ghent, BELGIUM – 3 August 2021 – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Biotalys NV (the “Company”) publishes the following information following the realisation of capital increases by issuance of new shares:

  • Share capital: €81,968,625.55

  • Total number of securities carrying voting rights: 30,805,551 (all ordinary shares)

  • Total number of voting rights (= denominator): 30,805,551 (all relating to ordinary shares)

  • Number of rights to subscribe for securities carrying voting rights not yet issued:

    • 2,642,628 “ESOP Warrants”, entitling their holders to subscribe for a total number of 2,642,628 profit certificates which will, if and when issued, automatically convert into a total number of maximum 1,321,314 securities carrying voting rights (all ordinary shares)

    • 1,759,241 “ESOP IV Warrants”, entitling their holders to subscribe for a total number of maximum 1,759,241 securities carrying voting rights (all ordinary shares).

ADVERTISEMENT

- ENDS -

For further information, please contact:

Biotalys
Toon Musschoot, Strategic Communications Manager
T: +32 (0)9 274 54 00
E: Toon.Musschoot@Biotalys.com

For media enquiries, please contact:
Consilium Strategic Communications
Amber Fennell, Chris Gardner, Chris Welsh
T: +44 (0)203 709 5700
E: Biotalys@consilium-comms.com

About Biotalys

Biotalys is an Agricultural Technology (AgTech) company focused on addressing food protection challenges with protein-based biocontrol solutions for more sustainable and safer food. Based on its novel AGROBODY™ technology platform, Biotalys aims to develop a strong and diverse pipeline of effective products with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology). The Company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.